RED ALERT! EUROPEAN DRUG REGULATOR GIVES APPROVAL FOR RISKY EBOLA VACCINE
THE EMA HAS GIVEN APPROVAL TO A RISKY EBOLA VACCINE
THE MERCK VACCINE HAS BEEN RENAMED ERVEBO
LIKELY TO GET A FULL MARKETING LICENSE FROM THE EC IN A FEW WEEKS
VACCINE HAS NOT RECEIVED REGULATORY LICENSE BECAUSE ITS TRIAL DESIGN, OF RING VACCINATION HAS YIELED DATA NOT DEEMED STRONG ENOUGH, ADMITS SCIENCE MAG.
MEANWHILE, EBOLA DRUGS LIKE MAB114 OR SURVIVORS BLOOD PROVEN TO CURE EBOLA ARE SIDELINED
NWO GLOBALIST EBOLA FALSE FLAG AND MEDICAL MARTIAL LAW IS ALSO A THREAT TO CHINA S HEALTH ANDECONOMY
CHINA SHOULD PLAN ITS OPTIONS
WHO hails 'triumph' as Merck's Ebola vaccine gets European green light
3 MIN READ
LONDON (Reuters) - The world’s first Ebola vaccine was recommended for approval by European drugs regulators on Friday in a move hailed by the World Health Organization (WHO) as a “triumph for public health” that would save many lives.
The vaccine, developed by U.S. drugmaker Merck & Co, is already being used under emergency guidelines to try to protect people against the spread of a deadly Ebola outbreak in Democratic Republic of Congo.
The Merck vaccine, which the company has now brand-named Ervebo, is likely to get a full marketing license from the European Commission in a few weeks.
Roger Perlmutter, president of Merck Research Laboratories, said the company’s priority now was to get regulatory approval of its Ervebo manufacturing site in Germany so that licensed supply of the vaccine “can be used to support global public health preparedness”.
Merck’s vaccine is being used in Congo in a so-called “ring vaccination” approach, in which people who may have been in contact with someone newly infected with Ebola are traced and offered the shot to protect them.
Charlie Weller, head of vaccines at the Wellcome Trust global heath charity said the Merck shot had already saved “countless lives” in the country.